Physician profile
Ei K Swe
NPI 1821352220
$8,960.22
in general payments reported to CMS, 2019-2025
17 companies · $3,555 in 2025
The $3,555 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2021: $464 · 2022: $525 · 2023: $449 · 2024: $3,780 · 2025: $3,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,663 · Food and Beverage: $3,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,662.64 |
| Food and Beverage | $3,120.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,845.69 | 2023-2025 | Evoque, Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $3,506.74 | 2021-2025 | Mitraclip, Navitor |
| Boston Scientific Corporation | $399.17 | 2019-2022 | |
| Medtronic, INC. | $327.67 | 2021-2025 | Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $205.99 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $161.59 | 2021-2024 | Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $125.89 | 2021-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $96.51 | 2019-2025 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.39 | 2019-2022 | |
| Philips North America LLC | $45.68 | 2022 | |
| Amgen INC. | $45.02 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $28.45 | 2025 | Amvuttra |
| Daiichi Sankyo INC. | $22.52 | 2025 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $17.06 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $16.05 | 2023 | Livalo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.50 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ei Swe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.